Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study-Reference-Cited by-同舟云学术

Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study

Published:2020-11-03 Issue:11 Volume:15 Page:e0240898
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tiddens Harm A. W. M.^ORCID,Andrinopoulou Eleni-Rosalina,McIntosh Joe,Elborn J. Stuart,Kerem Eitan,Bouma Nynke,Bosch Jochem,Kemner-van de Corput Mariette

Funder

PTC Therapeutics

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. Progressive damage on high-resolution computed tomography despite stable lung function in CF;PA de Jong;Eur Respir J,2004

2. Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis;DB Sanders;Am J Respir Crit Care Med,2011

3. Tracking CF disease progression with CT and respiratory symptoms in a cohort of children aged 6–19 years;LA Tepper;Pediatr Pulmonol,2014

4. Computed Tomography Correlates with Pulmonary Exacerbations in Children with Cystic Fibrosis;AS Brody;Am J Respir Crit Care Med,2005

5. Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial;E Kerem;Lancet Respir Med,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Dournes and Benlala: Hierarchical Computed Tomography Scoring Systems Cannot Discriminate Between Reversible Bronchiectasis and Mucus Plugs;American Journal of Respiratory and Critical Care Medicine;2024-04-15

2. Quantification of Proteus syndrome-associated lung disease;Orphanet Journal of Rare Diseases;2024-02-06

3. Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial;American Journal of Respiratory and Critical Care Medicine;2023-11-01

4. Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis;Thorax;2023-09-21

5. The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting;Respiratory Research;2023-08-11